Pilot Testing a Mobile App to Designed to Increase Physical Activity Among Pregnant and Postpartum Women

July 12, 2022 updated by: Rachel Tinius, Western Kentucky University

Pilot Testing of a Mobile Health Intervention Designed to Increase Physical Activity and Improve Morbidity and Mortality-related Outcomes Among Pregnant and Postpartum Women in a Rural Setting

The goal of this pilot project is to test the feasibility and potential efficacy of the evidence-based mHealth app (BumptUp) for improving physical activity and subsequent health outcomes (i.e. obesity, hypertension, insulin resistance) among pregnant and postpartum women in a rural community.

In order to accomplish this goal, feasibility of the intervention protocol will be tested by the assessment of recruitment (how many participants eligible per month), retention (% of women who complete the study protocol), adherence to intervention (% of women who utilize the app), and acceptability (survey and one-on-one exit interviews) during pregnancy and postpartum.

Potential efficacy will be determined by examining trends in data on physical activity levels (achieving the goal of 150 minutes per week of physical activity (surveys and accelerometry)) between groups. Other secondary outcomes will also be assessed: weight status, body composition, blood pressure, insulin resistance, fitness levels, mental health, and infant anthropometrics.

Clinical hypotheses:

  1. The mHealth program will be feasible as evidenced by high rates of enrollment, retention, and adherence, moderate-to-high levels of satisfaction, and low participant burden.
  2. The mHealth intervention will show promise towards improving physical activity levels and other secondary outcomes in pregnant and postpartum women in a rural community.

Study Overview

Detailed Description

After contact is established and eligibility confirmed, Participants (N=40) will be enrolled and baseline surveys will be conducted to collect information about lifestyle, mental health, and anxiety levels. Patient data for those participants who have agreed to be in the study and have specifically agreed on the consent form to allow the study team to pull data from their prenatal charts. The data being pulled from charts will include patient weights, vital signs, blood pressures, current complications, blood analytes, and glucose tolerance test results from each prenatal visit. After the baby is born, delivery reports will also be obtained in order to collect information on the delivery outcomes (gender, mode of delivery, complications, time in labor) and baby's anthropometric data (birthweight, birth length, head circumference).

Compensation will be in the form of Amazon gift cards (delivered electronically). There will be 4 time points where they take the online assessments. At each time point, they will also be mailed an Actigraph accelerometer to wear for one week. These will be sanitized and mailed or dropped off to avoid any contamination from the study team to participants. When the week is over, the study team will check in with participants and discuss a plan for pick up. They can leave outside for a study team member to pick up (contactless ) or they can mail it back (with provided return envelope).

Each participant will still receive a total of $160. They be recruited and consented online around 18-20 weeks. Assessments will occur at 4 timepoints: baseline assessments at 23-25 weeks gestation ($40), phone check at 30 weeks, second assessment/set of surveys at 35-37 weeks ($40), delivery outcomes obtained, 6 week postpartum surveys ($40), and 12 week postpartum surveys ($40).

Statistical Analyses:

Sample Size Determination: Sample size for this pilot study was determined based on previously performed physical activity interventions among pregnant women. The effect size (0.91) for the main outcome of physical activity was determined from looking at post-intervention physical activity data from Asci et al.83. With this effect size, it was determined using SAS software with a type I error rate of 0.05 that a sample size of 20 per group could detect this difference with 80% power, thus our sample size of 15 per group is justified for a pilot project.

Data Analyses:

Aim 1: To estimate the success and feasibility of recruitment methods, the number of people who will hear about the study via various methods (e.g. health care providers, health fairs, word-of-mouth) will be estimated. Then, the number of women who completed initial screening, the number of women who meet the eligibility criteria, the number of women who complete each of the assessments, the number of women randomized, and the number of women who adhere to the intervention will be determined. The exit interview data will be analyzed via standard content analyses for qualitative studies as previously described84 (and recently performed by our group). Aim 2: Although the investigators may not detect all between group differences because the investigators are proposing a pilot project, appropriate statistical tests will be performed in order to examine trends, and thus, promise for effect in the larger future trial. Normality of the distribution for each variable will be tested using Kolmogorov-Smirnov tests, and non-normally distributed data will be transformed as needed. The baseline characteristics of the two groups will be compared using t-tests or Chi square tests. The potential effect of the intervention on study outcomes will be explored using repeated measures ANOVAs (group x time). Specifically, physical activity data between groups will be compared from pre-post intervention. All data will be entered in Redcap data management system. Analyses will be conducted using SAS or other statistical software.

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Bowling Green, Kentucky, United States, 42101
        • Western Kentucky University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 44 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 1) Age 18-44
  • 2) Confirmed singleton viable pregnancy
  • 3) English-Speaking (the app is currently only available in English)
  • 4) Physician release to participate in exercise
  • 5) Ownership of a smart phone
  • 6) Plans to deliver at The Medical Center in Bowling Green, KY.

Exclusion Criteria:

  • 1) Multiple gestation pregnancy
  • 2) Inability to provide voluntary informed consent
  • 3) Any medical condition (pregnancy-related or not) that would preclude exercise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: mHealth Intervention Group
This group will be provided with the mobile health app (including introductory videos on how to use its features).
Access to the mobile health application with exercise plans and education
Sham Comparator: Control Group
This group will receive an educational brochure about physical activity during pregnancy.
An evidence-based educational brochure with general information about the benefits of physical activity during pregnancy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment feasibility during pregnancy
Time Frame: Pregnancy (23-25 weeks gestation)
how many participants eligible and successfully recruited per month
Pregnancy (23-25 weeks gestation)
Protocol retention
Time Frame: 12 weeks postpartum
% of women who complete the study protocol
12 weeks postpartum
Adherence to intervention
Time Frame: Pregnancy (35-37 weeks pregnant)
% of women who use the app daily
Pregnancy (35-37 weeks pregnant)
Adherence to intervention
Time Frame: Postpartum (12 weeks after delivery)
% of women who use the app daily
Postpartum (12 weeks after delivery)
Acceptability of Intervention
Time Frame: Postpartum (12 weeks after delivery)
measured via exit interviews
Postpartum (12 weeks after delivery)
Physical activity levels
Time Frame: Pregnancy (23-25 weeks gestation)
Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data
Pregnancy (23-25 weeks gestation)
Physical activity levels
Time Frame: Pregnancy (35-37 weeks gestation)
Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data
Pregnancy (35-37 weeks gestation)
Physical activity levels
Time Frame: Postpartum (12 weeks)
Assess the potential efficacy of the intervention by examining physical activity levels through objective actigraph data
Postpartum (12 weeks)
Physical activity levels
Time Frame: Postpartum (6 weeks)
Assess the potential efficacy of the intervention by examining physical activity levels through Exercise Vital Sign Survey
Postpartum (6 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal weight status
Time Frame: Pregnancy (23-25 weeks gestation)
Body weight (lbs)
Pregnancy (23-25 weeks gestation)
Maternal weight status
Time Frame: Pregnancy (35-37 weeks gestation)
Body weight (lbs)
Pregnancy (35-37 weeks gestation)
Maternal weight status
Time Frame: Postpartum (12 weeks post-delivery)
Body weight (lbs)
Postpartum (12 weeks post-delivery)
Maternal blood pressure
Time Frame: Pregnancy (23-25 weeks gestation)
Assessed by nurse at clinical visit using standardized clinical equipment
Pregnancy (23-25 weeks gestation)
Maternal blood pressure
Time Frame: Pregnancy (35-37 weeks gestation)
Assessed by nurse at clinical visit using standardized clinical equipment
Pregnancy (35-37 weeks gestation)
Maternal blood pressure
Time Frame: Postpartum (6 weeks post-delivery)
Assessed by nurse at clinical using standardized clinical equipment
Postpartum (6 weeks post-delivery)
Maternal insulin resistance
Time Frame: Pregnancy (24-29 weeks gestation)
Oral Glucose Tolerance Test Results
Pregnancy (24-29 weeks gestation)
Maternal endothelial dysfunction
Time Frame: Pregnancy (35-37 weeks gestation)
Assessed with a rapid, non-invasive technique that records endothelium-mediated changes in the peripheral arterial tone signal via a pair of finger probes
Pregnancy (35-37 weeks gestation)
Maternal postpartum depression
Time Frame: Postpartum (12 weeks post-delivery)
Edinburgh postpartum depression survey
Postpartum (12 weeks post-delivery)
Maternal mood
Time Frame: Pregnancy (23-25 weeks gestation)
Profile of Mood Survey
Pregnancy (23-25 weeks gestation)
Maternal mood
Time Frame: Pregnancy (35-37 weeks gestation)
Profile of Mood Survey
Pregnancy (35-37 weeks gestation)
Maternal mood
Time Frame: Postpartum (6 weeks post-delivery)
Profile of Mood Survey
Postpartum (6 weeks post-delivery)
Maternal mood
Time Frame: Postpartum (12 weeks post-delivery)
Profile of Mood Survey
Postpartum (12 weeks post-delivery)
Mental Health
Time Frame: Pregnancy (23-25 weeks gestation)
Center for Epidemiological Studies Depression Survey
Pregnancy (23-25 weeks gestation)
Mental Health
Time Frame: Pregnancy (35-37 weeks gestation)
Center for Epidemiological Studies Depression Survey
Pregnancy (35-37 weeks gestation)
Mental Health
Time Frame: Postpartum (6 weeks post-delivery)
Center for Epidemiological Studies Depression Survey
Postpartum (6 weeks post-delivery)
Mental Health
Time Frame: Postpartum (12 weeks post-delivery)
Center for Epidemiological Studies Depression Survey
Postpartum (12 weeks post-delivery)
Infant birthweight
Time Frame: At time of delivery
Collected at delivery by trained nursing staff
At time of delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 28, 2020

Primary Completion (Actual)

December 20, 2021

Study Completion (Actual)

May 1, 2022

Study Registration Dates

First Submitted

July 8, 2020

First Submitted That Met QC Criteria

July 16, 2020

First Posted (Actual)

July 22, 2020

Study Record Updates

Last Update Posted (Actual)

July 13, 2022

Last Update Submitted That Met QC Criteria

July 12, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 20-257

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on mHealth Intervention Group

3
Subscribe